Will NVIDIA Be Knocked Off Its Perch By Quantum?
Earlier this month, NVIDIA CEO Jensen Huang seemingly dashed the hopes of speculative tech investors banking on quantum computing to become the next big thing in the ever-advancing race for faster and faster computer processing. Huang, speaking at the Consumer Electronics Show, stated his view that practical quantum computers were still about two decades away, causing a selloff among the stocks of quantum startups. » Read more about: Will NVIDIA Be Knocked Off Its Perch By Quantum? »
Read More
Time to Buy Black Gold?
In spite of recent volatility, energy stocks have historically provided strong returns during periods of crude oil price recovery. With crude oil prices nearing the lower end of their range and a bullish shift in fundamentals, is now the time to begin long positions in the energy sector?
Crude oil is approaching the $70 per barrel mark,
» Read more about: Time to Buy Black Gold? »
Read More
Ominous Signal Strikes for First Time in 90 Years
If one key indicator is to be trusted, the U.S. economy may be headed either for choppy waters or over a cliff, and the fallout for stocks may be enormous.
While there is no doubt that the forces of money supply creation and consequently inflation drive nominal prices higher over the long-term, the short-term is less easy to forecast with the same degree of accuracy.
» Read more about: Ominous Signal Strikes for First Time in 90 Years »
Read More
Will This Silicon Valley Darling Topple The Market?
Silicon Valley darling, Salesforce, saw its stock fall 16% following last night’s fiscal Q1 2025 earnings report. Growth moderated to an 11% year-over-year increase, which was the lower end of the guidance and that was enough to spook investors.
Yet the woes continued when full-year revenue guidance of $37.7 billion to $38 billion was reported because it reflected a growth projection of just 8% to 9%.
» Read more about: Will This Silicon Valley Darling Topple The Market? »
Read More
Billionaire Buys Stake In Gene Therapy Stock
Ultragenyx may not have crossed your radar but it’s already in billionaire Stan Druckenmiller’s portfolio. What has he spotted in this novel therapies for rare and ultra-rare genetic diseases firm that convinced him to take a position?
Its focus on underserved patient populations, deep pipeline of innovative products, and strong track record in obtaining regulatory approvals make it an attractive long-term investment,
» Read more about: Billionaire Buys Stake In Gene Therapy Stock »
Read MoreThe Ivy
AI Bets and Buffett’s Seal of Approval, Is This a Bet on a Cashless Future?
There is something inherently attractive about buying a stock and holding it for a long time. Stable don’t just have strong balance sheets that can weather rough markets but they often pay dividends, which account for as much as 95% of total returns over the past century according to research by Wharton Professor Jeremy Siegel.
» Read more about: AI Bets and Buffett’s Seal of Approval, Is This a Bet on a Cashless Future? »
Read MoreThe Spotlight
AI Warren Buffett Is Finally Here
Before old Warren could hang up his gloves and call it a day at Berkshire Hathaway, a new wave of technology may well have taken his baton and started to run with it.
What do we mean? Well, it seems a new ETF has launched aimed at mimicking the moves of the top investors in the world.
» Read more about: AI Warren Buffett Is Finally Here »
Read MoreThe Daily
15 Most Crowded Hedge Fund Stocks That Are Targeted by Short Sellers
Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal!
My #1 AI stock pick delivered solid gains since the beginning of 2025 while popular AI stocks like NVDA and AVGO lost around 25%.
» Read more about: 15 Most Crowded Hedge Fund Stocks That Are Targeted by Short Sellers »